Oskar Hansson
Chief Investment Officer bei ABELCO INVESTMENT GROUP AB
Profil
Oskar Hansson is a Scientific Advisor and founder of Cell Invent Sweden AB, which is founded in 2019.
He is currently working as an Investment Manager at Abelco Investment Group AB since 2021.
Aktive Positionen von Oskar Hansson
| Unternehmen | Position | Beginn |
|---|---|---|
| ABELCO INVESTMENT GROUP AB | Chief Investment Officer | 01.06.2021 |
Cell Invent Sweden AB
 Cell Invent Sweden AB Miscellaneous Commercial ServicesCommercial Services Cell Invent Sweden AB is a company based in Lund, Sweden that develops new human disease models based on reprogrammed Alzheimer patient cells. The Swedish company is developing phenotype-based screening methods for drug discovery, drug development, and companion diagnostics development. The company was founded in 2019 by Håkan Toresson, Camilla Orbjörn, Lennart Minthon, Oskar Hansson, and Håkan Toresson has been the CEO since 2019. | Gründer | 01.01.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABELCO INVESTMENT GROUP AB | Producer Manufacturing |
| Private Unternehmen | 1 |
|---|---|
Cell Invent Sweden AB
Cell Invent Sweden AB Miscellaneous Commercial ServicesCommercial Services Cell Invent Sweden AB is a company based in Lund, Sweden that develops new human disease models based on reprogrammed Alzheimer patient cells. The Swedish company is developing phenotype-based screening methods for drug discovery, drug development, and companion diagnostics development. The company was founded in 2019 by Håkan Toresson, Camilla Orbjörn, Lennart Minthon, Oskar Hansson, and Håkan Toresson has been the CEO since 2019. | Commercial Services |
